Rachel Black
Adelaide Medical School
Faculty of Health and Medical Sciences
Rachel is a rheumatologist currently undertaking a PhD looking at the epidemiology of glucocorticoid use and adverse effects in inflammatory conditions including rheumatoid arthritis. Her interests include pharmacoepidemiology and the use of big data to answer questions directly relevant to her clinical practice in rheumatology.
-
Expand
-
Appointments
Date Position Institution name 2016 Clinical Lecturer University of Adelaide 2015 Consultant Rheumatologist Royal Adelaide Hospital -
Awards and Achievements
Date Type Title Institution Name Country Amount 2015 Scholarship Arthritis SA/Australian Rheumatology Association (SA) Postgraduate Grant — — — 2014 Scholarship Australian Postgraduate Award (The University of Adelaide) The University of Adelaide Australia — 2013 Fellowship Ken Muirden Overseas Training Fellowship Arthritis Research UK Centre for Epidemiology, The University of Manchester United Kingdom — -
Education
Date Institution name Country Title 1999 - 2004 The University of Adelaide Australia MBBS -
Postgraduate Training
Date Title Institution Country 2007 - 2012 FRACP Royal Australasian College of Physicians Australia -
Research Interests
-
Expand
-
Journals
Year Citation 2019 Cheah, J. T., Black, R. J., Robson, J. C., Navarro-Millán, I. Y., Young, S. R., Richards, P., . . . Hill, C. L. (2019). Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working Group.. The Journal of rheumatology.
2017 Black, R., Robson, J., Goodman, S., Hoon, E., Lai, L., Simon, L., . . . Hill, C. (2017). A patient-reported outcome measure for effect of glucocorticoid therapy in adults with inflammatory diseases is needed: Report from the OMERACT 2016 special interest group. Journal of Rheumatology, 44(11), 1754-1758.
Scopus12017 Mackie, S., Twohig, H., Neill, L., Harrison, E., Shea, B., Black, R., . . . Hill, C. (2017). The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica. Journal of Rheumatology, 44(10), 1515-1521.
Scopus4 WoS1 Europe PMC22017 Black, R., Goodman, S., Ruediger, C., Lester, S., Mackie, S., & Hill, C. (2017). A survey of glucocorticoid adverse effects and benefits in rheumatic diseases: The patient perspective. Journal of Clinical Rheumatology, 23(8), 416-420.
WoS1 Europe PMC12017 Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Research and Therapy, 19(1), 253-1-253-8.
Scopus1 WoS12016 Black, R., Hill, C., Lester, S., & Dixon, W. (2016). The association between systemic glucocorticoid use and the risk of cataract and glaucoma in patients with rheumatoid arthritis: A systematic review and meta- analysis. PLoS ONE, 11(11), e0166468.
Scopus22016 Hill, C., Black, R., Nossent, J., Ruediger, C., Nguyen, L., Ninan, J., & Lester, S. (2016). Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 46(4), 513-519.
Scopus12 WoS11 Europe PMC82015 Black, R., Joseph, R., Brown, B., Movahedi, M., Lunt, M., & Dixon, W. (2015). Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: A retrospective drug utilisation study. Arthritis Research and Therapy, 17(1), 375.
Scopus10 Europe PMC72014 Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Black, R., Ahern, M., . . . Hill, C. (2014). Epidemiology of biopsy-proven giant cell arteritis in South Australia. Internal Medicine Journal, 44(1), 32-39.
Scopus30 WoS25 Europe PMC182014 Black, R., Spargo, L., Schultz, C., Chatterton, B., Cleland, L., Lester, S., . . . Proudman, S. (2014). Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care & Research, 66(4), 515-522.
Scopus8 WoS8 Europe PMC52013 Black, R., Roach, D., Rischmueller, M., Lester, S., & Hill, C. (2013). The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice. International Journal of Rheumatic Diseases, 16(3), 352-357.
Scopus7 WoS4 Europe PMC42013 Dunstan, E., Lester, S., Black, R., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2013). No association between FCγR3B copy number variation and susceptibility to biopsy-proven giant cell arteritis. Arthritis, 2013, 514914-1-514914-4.
Europe PMC12012 Black, R., Lester, S., Dunstan, E., Shahram, F., Nadji, A., Bayat, N., . . . Davatchi, F. (2012). Fc-gamma receptor 3B copy number variation is not a risk factor for Behçet’s disease. International Journal of Rheumatology, 2012, 1-4.
Scopus3 Europe PMC22011 Black, R. J., Limaye, V., & Cleland, L. (2011). Acute Monoarthritis: What should one do?. Medicine Today: the peer reviewed journal of clinical practice, 12(3), 49-55. -
Conference Items
Connect With Me
External Profiles
